Kolexia
Karila Chantal
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
49 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hypersensibilité Mucoviscidose Hypersensibilité alimentaire Fibrose Asthme Hypersensibilité médicamenteuse Anaphylaxie Hypersensibilité immédiate Maladies pulmonaires

Industries

Sanofi
3 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2020
GSK
1 collaboration(s)
Dernière en 2020
AstraZeneca
1 collaboration(s)
Dernière en 2020

Dernières activités

SERAP: Epidemiological Survey on Perioperative Hypersensitivity Reactions in France by the GERAP Network (Groupe d'étude Des réactions Anaphylactiques périopératoires)
Essai Clinique (CHU Strasbourg)   02 mai 2023
Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   06 juillet 2022
Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF).
American journal of respiratory and critical care medicine   11 février 2022
Efficacy of oral ondansetron in acute FPIES: A case series of 6 patients.
Allergy   18 mai 2020
Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.
American journal of respiratory and critical care medicine   13 janvier 2020
EducAA: Impact of the Therapeutic Education on the Quality of Life of the Child From 8 to 12 Years Old (and His Family) Suffering of Food Allergy IgE-mediated.
Essai Clinique (Assistance publique – Hôpitaux de Paris)   15 avril 2019
ACTIVATE-CF: Effects of a Partially Supervised Conditioning Program in CF: an International Multi-centre, Randomized Controlled Trial
Essai Clinique (Wuerzburg University Hospital)   18 octobre 2018
Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol.
BMC pulmonary medicine   08 février 2018
CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.
Annals of the American Thoracic Society   15 novembre 2017
Mucoviscidose
HAS Publications   01 septembre 2017